OCM2
gene geneOn this page
Summary
OCM2 (oncomodulin 2, HGNC:34396) is a protein-coding gene on chromosome 7q21.3, encoding Oncomodulin-2 (P0CE71).
This gene is similar to the oncomodulin gene, a high-affinity calcium ion-binding protein that belongs to the superfamily of calmodulin proteins, also known as the EF-hand proteins.
Source: NCBI Gene 4951 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 21 total
- MANE Select transcript:
NM_006188
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:34396 |
| Approved symbol | OCM2 |
| Name | oncomodulin 2 |
| Location | 7q21.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000135175 |
| Ensembl biotype | protein_coding |
| OMIM | 620522 |
| Entrez | 4951 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 1 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000257627, ENST00000473987
RefSeq mRNA: 1 — MANE Select: NM_006188
NM_006188
CCDS: CCDS5653
Canonical transcript exons
ENST00000257627 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001788818 | 97990044 | 97990196 |
| ENSE00003553931 | 97987047 | 97987156 |
| ENSE00003628323 | 97988416 | 97988548 |
| ENSE00003978289 | 97984687 | 97984983 |
Expression profiles
Bgee: expression breadth broad, 33 present calls, max score 90.92.
Top tissues by expression
101 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 90.92 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 74.35 | gold quality |
| colonic epithelium | UBERON:0000397 | 41.93 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| bone marrow | UBERON:0002371 | 35.64 | silver quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| prefrontal cortex | UBERON:0000451 | 33.72 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| tonsil | UBERON:0002372 | 32.72 | gold quality |
| placenta | UBERON:0001987 | 32.33 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| primary visual cortex | UBERON:0002436 | 31.49 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| lymph node | UBERON:0000029 | 30.83 | silver quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| blood | UBERON:0000178 | 29.76 | gold quality |
| frontal cortex | UBERON:0001870 | 29.56 | gold quality |
| monocyte | CL:0000576 | 29.11 | silver quality |
| leukocyte | CL:0000738 | 28.97 | silver quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 27.99 | gold quality |
| skin of abdomen | UBERON:0001416 | 27.88 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 27.79 | silver quality |
| zone of skin | UBERON:0000014 | 27.74 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 27.59 | gold quality |
| cerebral cortex | UBERON:0000956 | 27.52 | gold quality |
| skin of leg | UBERON:0001511 | 27.21 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.10 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): EGR1, HIF1A
miRNA regulators (miRDB)
26 targeting OCM2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-7-1-3P | 99.91 | 71.53 | 4384 |
| HSA-MIR-7-2-3P | 99.91 | 71.40 | 4394 |
| HSA-MIR-627-3P | 99.90 | 71.42 | 3316 |
| HSA-MIR-6764-5P | 99.75 | 67.89 | 2304 |
| HSA-MIR-3158-5P | 99.65 | 67.51 | 1763 |
| HSA-MIR-298 | 99.63 | 67.56 | 1916 |
| HSA-MIR-1915-3P | 99.58 | 66.79 | 1988 |
| HSA-MIR-1275 | 99.47 | 67.90 | 2749 |
| HSA-MIR-328-5P | 99.08 | 64.65 | 1000 |
| HSA-MIR-6885-5P | 98.71 | 64.33 | 902 |
| HSA-MIR-4317 | 98.49 | 67.09 | 987 |
| HSA-MIR-1262 | 98.17 | 66.52 | 757 |
| HSA-MIR-4701-3P | 98.17 | 66.25 | 788 |
| HSA-MIR-6736-5P | 98.17 | 66.43 | 760 |
| HSA-MIR-6757-5P | 98.08 | 65.50 | 724 |
| HSA-MIR-4665-5P | 97.91 | 67.69 | 1536 |
| HSA-MIR-3127-5P | 97.52 | 65.24 | 786 |
| HSA-MIR-6514-3P | 97.52 | 66.50 | 808 |
| HSA-MIR-509-3-5P | 97.21 | 67.74 | 1517 |
| HSA-MIR-509-5P | 97.21 | 67.90 | 1512 |
| HSA-MIR-4418 | 97.04 | 67.16 | 1372 |
| HSA-MIR-12128 | 96.67 | 66.98 | 1471 |
| HSA-MIR-6866-5P | 96.64 | 68.06 | 624 |
| HSA-MIR-6790-3P | 88.15 | 62.55 | 113 |
Literature-anchored findings (GeneRIF, showing 1)
- This study deministrated that Parvalbumin-immunoreactive neurons in the human claustrum. (PMID:23832597)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | pvalb5 | ENSDARG00000032836 |
| mus_musculus | Ocm | ENSMUSG00000029618 |
| rattus_norvegicus | Ocm | ENSRNOG00000001031 |
Paralogs (2): PVALB (ENSG00000100362), OCM (ENSG00000122543)
Protein
Protein identifiers
Oncomodulin-2 — P0CE71 (reviewed: P0CE71)
All UniProt accessions (1): P0CE71
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the parvalbumin family.
RefSeq proteins (1): NP_006179* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002048 | EF_hand_dom | Domain |
| IPR008080 | Parvalbumin | Family |
| IPR011992 | EF-hand-dom_pair | Homologous_superfamily |
| IPR018247 | EF_Hand_1_Ca_BS | Binding_site |
Pfam: PF13499
UniProt features (13 total): binding site 10, domain 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P0CE71-F1 | 91.63 | 0.82 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (10): 95; 97; 102; 52; 54; 56; 58; 63; 91; 93
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 42 (showing top):
MIR298, MIR3158_5P, MIR509_5P, MIR509_3_5P, MIR12128, MIR4418, MIR4701_3P, MIR1262, MIR6736_5P, MIR6866_5P, GSE1448_ANTI_VALPHA2_VS_VBETA5_DP_THYMOCYTE_UP, GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_UP, GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_DN, GSE25087_FETAL_VS_ADULT_TREG_DN, GSE26928_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP
GO Biological Process (0):
GO Molecular Function (2): calcium ion binding (GO:0005509), metal ion binding (GO:0046872)
GO Cellular Component (1): cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| metal ion binding | 1 |
| cation binding | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
1365 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OCM2 | SLC26A5 | P58743 | 903 |
| OCM2 | PITPNM1 | O00562 | 864 |
| OCM2 | GFI1 | Q99684 | 758 |
| OCM2 | STRC | Q7RTU9 | 535 |
| OCM2 | ADCY6 | O43306 | 512 |
| OCM2 | OTOF | Q9HC10 | 496 |
| OCM2 | POU4F3 | Q15319 | 455 |
| OCM2 | TMC1 | Q8TDI8 | 437 |
| OCM2 | MINAR2 | P59773 | 435 |
| OCM2 | PAIP2B | Q9ULR5 | 426 |
| OCM2 | ATP1B3 | P54709 | 425 |
| OCM2 | ATOH1 | Q92858 | 410 |
| OCM2 | SLC1A1 | P43005 | 363 |
| OCM2 | TMC2 | Q8TDI7 | 360 |
| OCM2 | KCNA10 | Q16322 | 359 |
IntAct
8 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MED12 | MED14 | psi-mi:“MI:0914”(association) | 0.640 |
| OCM2 | ZMYM6 | psi-mi:“MI:0915”(physical association) | 0.400 |
| OCM2 | TERF1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| OCM2 | TERF2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| OCM2 | TERF2IP | psi-mi:“MI:0915”(physical association) | 0.370 |
| ARFGAP2 | OCM2 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNF708 | OCM2 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (7): ZMYM6 (Affinity Capture-MS), OCM2 (Affinity Capture-MS), OCM2 (Affinity Capture-MS), OCM2 (Affinity Capture-MS), OCM2 (Two-hybrid), OCM2 (Two-hybrid), OCM2 (Two-hybrid)
ESM2 similar proteins: A0A1B0GWK0, O01305, O35508, P02613, P02615, P02616, P02624, P02626, P02627, P02629, P02630, P02631, P02637, P04109, P04110, P04111, P04573, P05941, P09485, P0CE71, P0CE72, P13833, P15844, P18087, P19753, P21788, P25027, P30187, P30563, P34368, P41045, P43305, P51434, P51879, P80026, P80050, P80079, P80080, P82978, Q03975
Diamond homologs: A0A1B0GWK0, A0A3F2YLV2, A0A7M4EAX1, D3GME4, O35508, O49717, P02614, P02615, P02616, P02617, P02618, P02619, P02620, P02621, P02622, P02623, P02624, P02625, P02626, P02627, P02628, P02629, P02630, P02631, P05939, P05940, P05941, P09227, P0CE71, P0CE72, P18087, P19753, P20472, P30563, P32848, P43305, P51434, P51879, P56503, P59747
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
21 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 19 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
575 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:97987045:AC:A | donor_gain | 1.0000 |
| 7:97987046:CC:C | donor_gain | 1.0000 |
| 7:97987046:CCCT:C | donor_gain | 1.0000 |
| 7:97988414:A:AC | donor_gain | 1.0000 |
| 7:97988415:C:CT | donor_gain | 1.0000 |
| 7:97988418:A:AC | donor_gain | 1.0000 |
| 7:97988418:AAG:A | donor_gain | 1.0000 |
| 7:97988418:AAGCT:A | donor_gain | 1.0000 |
| 7:97987032:CA:C | donor_gain | 0.9900 |
| 7:97987040:GACAT:G | donor_loss | 0.9900 |
| 7:97987042:CAT:C | donor_loss | 0.9900 |
| 7:97987044:T:TA | donor_loss | 0.9900 |
| 7:97987045:A:AC | donor_gain | 0.9900 |
| 7:97987045:ACCCT:A | donor_loss | 0.9900 |
| 7:97987046:C:CC | donor_gain | 0.9900 |
| 7:97988415:CTT:C | donor_gain | 0.9900 |
| 7:97988415:CTTA:C | donor_gain | 0.9900 |
| 7:97988419:A:C | donor_gain | 0.9900 |
| 7:97988545:GGGTC:G | acceptor_gain | 0.9900 |
| 7:97988546:GGTCT:G | acceptor_gain | 0.9900 |
| 7:97988547:GTCT:G | acceptor_gain | 0.9900 |
| 7:97988549:C:CC | acceptor_gain | 0.9900 |
| 7:97990052:T:A | donor_gain | 0.9900 |
| 7:97987152:AAAAC:A | acceptor_gain | 0.9800 |
| 7:97987157:C:CA | acceptor_loss | 0.9800 |
| 7:97987158:T:C | acceptor_loss | 0.9800 |
| 7:97988410:G:C | donor_gain | 0.9800 |
| 7:97988415:CT:C | donor_gain | 0.9800 |
| 7:97988415:CTTAA:C | donor_gain | 0.9800 |
| 7:97988548:TCT:T | acceptor_gain | 0.9800 |
AlphaMissense
736 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:97988466:G:C | F48L | 0.995 |
| 7:97988466:G:T | F48L | 0.995 |
| 7:97988468:A:G | F48L | 0.995 |
| 7:97984980:A:G | F103S | 0.993 |
| 7:97987080:C:G | D91H | 0.991 |
| 7:97988419:A:G | L64P | 0.991 |
| 7:97984979:G:C | F103L | 0.990 |
| 7:97984979:G:T | F103L | 0.990 |
| 7:97984981:A:G | F103L | 0.990 |
| 7:97988456:C:G | D52H | 0.990 |
| 7:97988467:A:G | F48S | 0.990 |
| 7:97988455:T:A | D52V | 0.989 |
| 7:97988521:A:G | F30S | 0.989 |
| 7:97988520:G:C | F30L | 0.988 |
| 7:97988520:G:T | F30L | 0.988 |
| 7:97988522:A:G | F30L | 0.988 |
| 7:97987079:T:A | D91V | 0.987 |
| 7:97987079:T:G | D91A | 0.987 |
| 7:97988455:T:G | D52A | 0.987 |
| 7:97984980:A:C | F103C | 0.986 |
| 7:97987094:A:G | L86S | 0.985 |
| 7:97988419:A:T | L64H | 0.985 |
| 7:97987138:A:C | F71L | 0.984 |
| 7:97987138:A:T | F71L | 0.984 |
| 7:97987140:A:G | F71L | 0.984 |
| 7:97988434:A:G | L59P | 0.984 |
| 7:97988442:G:C | S56R | 0.984 |
| 7:97988442:G:T | S56R | 0.984 |
| 7:97988444:T:G | S56R | 0.984 |
| 7:97987058:A:T | I98N | 0.983 |
dbSNP variants (sampled 300 via entrez): RS1000349617 (7:97984943 C>T), RS1001241628 (7:97989399 T>G), RS1003530452 (7:97988308 C>G,T), RS1007389807 (7:97991748 A>T), RS1007609165 (7:97985766 A>C), RS1008054172 (7:97988986 A>G), RS1008075966 (7:97985359 C>T), RS1008279193 (7:97992062 A>C), RS1008562584 (7:97984644 G>C), RS1009031376 (7:97984413 GA>G), RS1010343607 (7:97984453 C>T), RS1010910150 (7:97990625 A>T), RS1011577503 (7:97987979 G>A), RS1011860582 (7:97989639 C>T), RS1014303245 (7:97991356 T>C)
Disease associations
OMIM: gene MIM:620522 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001099_14 | Sudden cardiac arrest | 2.000000e-06 |
| GCST006922_15 | Regular attendance at a religious group | 9.000000e-09 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004278 | sudden cardiac arrest |
| EFO:0009592 | social interaction measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | increases methylation | 1 |
| Cadmium | decreases expression | 1 |
| Folic Acid | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Asbestos, Serpentine | increases methylation | 1 |
| Lactic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.